Elevated Circulating LINC-P21 Serves as a Diagnostic Biomarker of Type 2 Diabetes Mellitus and Regulates Pancreatic β-cell Function by Sponging miR-766-3p to Upregulate NR3C2

Clicks: 179
ID: 260789
2020
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
All the data demonstrated that serum elevated LINC-P21 and decreased miR-766-3p serve as candidate diagnostic biomarkers in T2DM patients. LINC-P21 acts as a potential regulator in insulin secretion and proliferation of pancreatic β-cells through targeting miR-766-3p to upregulate NR3C2.
Reference Key
z2020experimentalelevated Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Cao Z;Yao F;Lang Y;Feng X;;
Journal experimental and clinical endocrinology & diabetes : official journal, german society of endocrinology [and] german diabetes association
Year 2020
DOI DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/33007789
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE pubmed abstract nih national institutes of health national library of medicine pmid:33007789 doi:10.1055/a-1247-4978 zhibin cao fuwang yao xueqiang feng

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.